Nuzenio

Vxa

Vxa news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 7 publisher sources 100/100 entity strength

Latest news

VERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -citybuzz - · Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 18:30:00 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:20 GMTUpcoming & Recent IPO's - IPOs Calendar - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:08:38 GMTVeraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward - Stock TitanStock Titan · Mon, 27 Jul 2026 20:05:50 GMTVERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration - The Globe and MailThe Globe and Mail · Mon, 27 Jul 2026 17:43:00 GMTVERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb - The Manila TimesThe Manila Times · Mon, 27 Jul 2026 11:17:21 GMTVERAXA Biotech Announces Advancement of VXA-222 Bispecific ADC Program in Collaboration with OmniAb - Quiver QuantitativeQuiver Quantitative · Mon, 27 Jul 2026 11:13:00 GMT

Timeline

Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -
Thu, 06 Aug 2026 18:30:00 GMTVERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo Finance
Thu, 06 Aug 2026 00:24:20 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -
Mon, 03 Aug 2026 12:08:38 GMTUpcoming & Recent IPO's - IPOs Calendar - Yahoo Finance
Mon, 27 Jul 2026 20:05:50 GMTVeraxa Biotech (VRXA) moves bispecific ADC VXA-222 program forward - Stock Titan
Mon, 27 Jul 2026 17:43:00 GMTVERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration - The Globe and Mail

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Vxa.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.